NanoLogix to Exhibit at Food Safety Summit in Baltimore and American Society for Microbiology Annual Meeting in Denver
April 30 2013 - 6:00AM
Business Wire
NanoLogix Inc. (OTC: NNLX), an innovator in the accelerated
detection, identification and antibiotic sensitivity determination
of live bacteria announces that they will exhibit their microbial
detection and diagnostic technologies at both the Food Safety
Summit in Baltimore 30 April – May 2 and the American Society for
Microbiology Annual Meeting in Denver 18-21 May.
The Company will exhibit at booth 924 in the Baltimore
Convention Center, Halls A-C.
Further information is available at:
http://www.foodsafetysummit.com/
In Denver, the Company will exhibit at booth 1244 in the
Colorado Convention Center, Halls A and B. Further information on
the event is available at: http://gm.asm.org/
NanoLogix has posted an operations update for 2012-13 at:
www.nanologix.com.
About NanoLogix, Inc.
NanoLogix is a biotechnology company focused primarily on rapid
diagnostics. Its products offer accelerated detection and
identification of microorganisms. In addition to medical and
homeland security applications, NanoLogix technology is applicable
in pharmaceutical, industrial, veterinary and environmental
testing.
Patents granted to NanoLogix can be used in the areas of applied
microbiology, soil microbiology and bioremediation, microbial
physiology, molecular biology, pharmacology, pharmaco-kinetics, and
antibiotic sensitivity
For more information visit www.nanologix.com.
This press release contains statements, which may constitute
"forward- looking statements" within the meaning of the Securities
Act of 1933 and the Securities Exchange Act of 1934, as amended by
the Private Securities Litigation Reform Act of 1995. Those
statements include statements regarding the intent, belief or
current expectations of NanoLogix, Inc., and members of its
management as well as the assumptions on which such statements are
based. Prospective investors are cautioned that any such
forward-looking statements are not guarantees of future performance
and involve risks and uncertainties, and that actual results may
differ materially from those contemplated by such forward-looking
statements. The Company undertakes no obligation to update or
revise forward-looking statements to reflect changed assumptions,
the occurrence of unanticipated events or changes to future
operating results.
NanoLogix (CE) (USOTC:NNLX)
Historical Stock Chart
From Nov 2024 to Dec 2024
NanoLogix (CE) (USOTC:NNLX)
Historical Stock Chart
From Dec 2023 to Dec 2024